BridgeMD
New treatment option for Intermittent Catheterization
Official title Conversion of Evidence and Applied Research on Intermittent Catheterization After Radical Hysterectomy
ClinicalTrials.gov ID: NCT06529107
What this study is testing
- What it's testing
- In this study, the investigators summarize the existing best evidence of intermittent catheterization in patients after radical cervical cancer surgery from the perspective of clinical translation of evidence through systematic search, evaluation and evidence integration, construct a nursing protocol of intermittent catheterization for patients after radical cervical cancer surgery based on the best evidence combined with the clinical context, and explore the clinical application effect of the above nursing protocol. It will provide a reference basis for the development of the standardization and management of intermittent catheterization for postoperative patients with cervical cancer in China, as well as the development of guidelines for intermittent catheterization after radical cervical cancer surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Age ≧ 18 years old
- Radical cervical cancer surgery and intermittent catheterization were performed at the Institute's hospital
- Patients or their family members can operate a smartphone
- No cognitive or psychiatric disorders, and can communicate effectively
You likely can't join if
- People with serious heart, brain, lung and other important organ diseases
- People with water, electrolyte, acid-base balance disorders at the beginning of intermittent catheterization
- People with previous serious renal diseases, bladder and urethra surgery
- People with urinary tract infections
- People who did not complete all interventions or data collection
- People who voluntarily withdrew from the study or died during the study period;
See the full eligibility criteria
- Age ≧ 18 years old
- Radical cervical cancer surgery and intermittent catheterization were performed at the Institute's hospital
- Patients or their family members can operate a smartphone
- No cognitive or psychiatric disorders, and can communicate effectively
- People with serious heart, brain, lung and other important organ diseases
- People with water, electrolyte, acid-base balance disorders at the beginning of intermittent catheterization
- People with previous serious renal diseases, bladder and urethra surgery
- People with urinary tract infections
- People who did not complete all interventions or data collection
- People who voluntarily withdrew from the study or died during the study period;
- Refuse to participate in this study
The study team makes the final eligibility decision.
Where it's taking place
- Chengdu, Sichuan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chengdu, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.